Bioactive injectable hydrogels for soft tissue regeneration after reconstructive maxillofacial surgeries - INJECT-BIO

Project summary

Oral soft tissue regeneration after ablative surgery or trauma is still a challenging goal in today’s clinical routine. Currently available biomaterials in the market act as soft tissue fillers, but cannot ensure the bioactive response and/or ingrowth of gum-derived cells. In INJECT-BIO project, the development of advanced biomaterials and drug delivery systems for oral soft tissue regeneration will be investigated by applying Halomanas levan and bacterial cellulose-based injectable hydrogels containing IGF-1 and cannabis extract/cannabidiol liposomal simultaneous delivery systems. The project consortium unites the expertise, complementary skills and infrastructure of researchers and professionals from 5 countries – Latvia, Lithuania, Israel, Turkey and Czech Republic. The INJECT-BIO project will generate advanced know-how and knowledge of hydrogel-cell interactions leading the product till TRL4, giving a great potential for INJECT-BIO results to be transferred in the market.

Project Details

Call

Call 2019


Call Topic

New strategies for advanced material-based technologies in health applications


Project start

01.10.2020


Project end

30.09.2023


Total project costs

647.191 €


Total project funding

566.000 €


TRL

3 - 4


Coordinator

Dr. Arita Dubnika

Riga Technical University, Kalku street 1, LV-1658 Riga, Latvia


Partners and Funders Details

Consortium Partner   Country Funder
Riga Technical University
https://www.rtu.lv, www.rbiac.rtu.lv
University Latvia LV-VIAA
State Research Institute Centre for Innovative Medicine
https://www.imcentras.lt/en/
Research org. Lithuania LT-RCL
Marmara University
https:////ibsb.bioe.eng.marmara.edu.tr/
University Turkey TR-TUBITAK
Tomas Bata University in Zlin
http://cps.utb.cz/en/
University Czech Republic CZ-TACR
Technion-Israel Institute of Technology
https://www.technion.ac.il/en/home-2/
University Israel IL-MOST IL

Keywords

medical device, drug delivery, bioactive materials